Paragon Genomics, founded in 2016 and based in Hayward, United States, focuses on providing advanced genomic solutions. The company's core mission is to enhance genomic research and diagnostics through their innovative CleanPlex® technology, which offers amplicon-based NGS panels for sequencing. Their products cater to various application markets, including infectious disease, precision oncology, inherited disease, and molecular breeding. Paragon Genomics aims to deliver high-quality, rapid, and customizable NGS target enrichment solutions.
Notable affiliated individuals include Professor Edwin Oh from the University of Nevada, who has utilized Paragon's technology for single viral copy detection in wastewater samples. The company has achieved significant milestones in genomic testing and research, particularly in the areas of infectious disease and precision oncology. Paragon Genomics' impact is evident in its contribution to advancing genomic research methodologies and improving diagnostic accuracy across multiple fields.
